Aculys Pharma Delivers Positive Phase 3 Clinical Study Interim Analysis result of a Diazepam Nasal Spray | An Antiepileptic Drug for RX of Epileptic Seizuresnews2023-10-18T11:01:24+00:00October 18th, 2023|Medical Device News Magazine|
Brise Pharma Announces First Patient Dosed with BR01T in Phase I Study in Patients with Chronic Low Back Painnews2023-10-18T10:57:27+00:00October 18th, 2023|Medical Device News Magazine|
NICO Corporation Awards $40,000 Grant to London’s Kings College Hospitalnews2023-10-12T20:21:11+00:00October 12th, 2023|Medical Device News Magazine|
Daye Announces Clinical Trial Launches to Develop Diagnostic Tampon for At-home STI and HPV Testingnews2023-10-12T20:09:59+00:00October 12th, 2023|Medical Device News Magazine|
CARsgen’s CAR-GPC3 T-cell Therapy for Advanced Hepatocellular Carcinoma: Two Patients Achieved over 7 Years of Disease-free Survivalnews2023-10-12T14:04:04+00:00October 12th, 2023|Medical Device News Magazine|
Cyrano Therapeutics Enrolls First Patient in Phase 2 Trial of CYR-064 for Post-Viral Smell Loss (Hyposmia)news2023-10-12T13:59:21+00:00October 12th, 2023|Medical Device News Magazine|
Suvoda Introduces Advanced Drug Optimization For IRT to Improve Accuracy of Clinical Trial Drug Supply Managementnews2023-10-12T13:49:20+00:00October 12th, 2023|Medical Device News Magazine|
New Data Presented at CHEST 2023 Demonstrate the Clinical Utility of Veracyte’s Envisia Genomic Classifier for Patients with Interstitial Lung Diseasenews2023-10-12T13:42:07+00:00October 12th, 2023|Medical Device News Magazine|
Salubris Biotherapeutics Presents Positive 6-Month Data from Phase 1b Clinical Trial of JK07 in Late-Breaking Session at The Heart Failure Society of America Annual Meeting 2023news2023-10-09T14:43:03+00:00October 9th, 2023|Medical Device News Magazine|
Neoadjuvant Study with LTX-315 In Early-stage Melanoma Patients to be Presented at the 15th Nordic Melanoma Meetingnews2023-10-09T14:22:07+00:00October 9th, 2023|Medical Device News Magazine|
